NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

血液動力學監測系統全球市場:通過技術創新和製定治療標準促進市場增長(2025)

Technology Innovations and Evolving Standard of Care Fueling Growth of the Global Hemodynamic Monitoring Systems Market, 2025

出版商 Frost & Sullivan 商品編碼 969474
出版日期 內容資訊 英文 98 Pages
商品交期: 最快1-2個工作天內
價格
血液動力學監測系統全球市場:通過技術創新和製定治療標準促進市場增長(2025) Technology Innovations and Evolving Standard of Care Fueling Growth of the Global Hemodynamic Monitoring Systems Market, 2025
出版日期: 2020年10月29日內容資訊: 英文 98 Pages
簡介

全球血液循環監測系統市場顯示了企業併購(M&A)的進展,最新業務模式的推出,技術創新的結果以及諸如新冠狀病毒感染(COVID-19)等傳染病。由於該疾病的流行,預計將發生重大變化。特別是,微創/無創技術的引入以及無線/可穿戴產品的引入將對未來的市場趨勢產生重大影響。

本報告分析了全球血液循環監測系統市場的最新技術和市場趨勢,概述了技術和產品,基本市場結構,主要市場促進/限制因素以及整體市場規模。除了調查趨勢前景,按技術方法和地區劃分的詳細趨勢,主要公司的概況等,我們還考慮未來的增長機會和問題,以及行業利益相關者未來應採取的策略。

目錄

戰略挑戰

  • 為什麼增長更加困難?
  • 關於戰略要務8□
  • 全球血液動力學監測系統行業的戰略挑戰
  • 三大戰略挑戰:對血流動力學監測系統市場的影響
  • 通過增長機會促進戰略要務8□

增長機會分析:血液循環監測系統市場

  • 血液循環監測系統市場:定義
  • 分析範圍
  • 市場細分:按治療設置
  • 市場分類:按產品/技術分類
  • 血液循環監測系統市場:各領域的主要公司
  • 血液動力學監測的主要內容
  • 理想的血液動力學監測方法:重要方面
  • 一系列護理方法
  • 主要影響因素
  • 增長趨勢
  • 血液動力學監測系統市場的主要增長指標
  • 主要收購
  • 技術職位
  • 推動血液循環監測系統市場的因素
  • 抑制血液循環監測系統市場的因素
  • 市場預測的前提條件:血液循環監測系統市場
  • 市場收入預測,快照
  • 市場收入預測:血液循環監測系統市場
  • 市場收入預測:按產品
  • 市場收入預測:通過設置
  • 市場收入預測:按地區
  • 市場收入預測:(入侵)按技術劃分
  • 市場收入預測:(微創)技術
  • 市場收入預測:(非侵入性)技術
  • 利潤預測分析,血液循環監測系統市場
  • 競爭環境:血液循環監測系統市場
  • 市場收入份額:大公司
  • 競爭環境:適用於大型公司
  • 主要公司的優先領域
  • 愛德華茲生命科學
  • Nihon Kohden
  • ICU Medical
  • 葛汀
  • 德拉格
  • 富士SonoSite
  • Deltex Medical
  • 維貢
  • Uscom
  • LiDCO
  • Physicon(佳能醫療集團)
  • OSYPKA Medical(心血管)
  • NI Medical
  • 獵豹醫療(巴克斯特)
  • 飛利浦
  • CN系統
  • 血液循環監測市場:其他初創公司的概述

北美血液循環監測系統市場:增長機會分析

  • 主要增長指標
  • 市場收入預測
  • 市場收入預測:按產品

歐洲血液循環監測系統市場:增長機會分析

亞太血液循環監測系統市場:增長機會分析

增長機會:血液循環監測系統市場

  • 增長機會(1):提供高級算法和混合功能的集成平台解決方案
  • 增長機會(2):術中無創產品
  • 增長機會(3):固定價格,自我更新的SaaS業務模型
  • 增長機會(4):用於遠程監控/替代治療的無線/便攜式/可穿戴設備
  • 增長機會(5):亞太市場對重症監護的人數和興趣都在增加

下一步

目錄
Product Code: K517-54

Increased Competitive Intensity Driving Transformational Growth through M&A, Innovative Business Models, and New Product Development

Hemodynamic monitoring aims to guide medical management of critically ill patients who are prone to hemodynamic instability. It performs the function of assessing the blood volume and oxygen perfusion, along with other parameters, to prevent or treat organ failure and improve the outcomes for patients. This study aims to analyze and forecast the market outlook for hemodynamic monitoring systems in North America, European Union (EU), and Asia-Pacific (APAC). It profiles major companies in the hemodynamic monitoring systems market and provides recommendations on growth opportunities. In a viral pandemic like the ongoing Coronavirus 2019 (COVID-19), monitoring of oxygen perfusion and hypotension in ICU and critical care units is vital to prevent complications like sepsis, acute respiratory distress syndrome (ARDS), and organ dysfunction. Amid this backdrop, there could be a strong demand for hemodynamic monitoring in ICUs, which could highlight the lack of capacity among existing suppliers. While in the first half 2020, cancellation of elective surgeries has contracted the demand for devices used in the perioperative setting, in the second half, it is expected to be offset by factors like greater demand in ICUs for managing COVID-19 patients and pent-up demand due to the uptick in elective surgery volumes. The market for hemodynamic monitoring systems is showing steady growth due to factors such as: Rising Importance of fluid management driven by goal-directed therapy, need for optimizing fluid status and perfusion throughout the continuum of care, and increasing number of surgeries and critical care admissions due to rising prevalence of chronic morbidities. The competitive landscape in the hemodynamic monitoring systems market is undergoing constant transformation, specifically in the non-invasive segment, with innovative start-ups offering wireless, wearable, and easy-to-administer technologies. These technologies enable continuity and access to care through remote monitoring in situations like the recent COVID-19 pandemic and other natural calamities. Established players are building hybrid, integrated platform solutions with advanced algorithms, combining minimally invasive and non-invasive methods to meet the changing requirements of physicians across the continuum of care. While pulmonary artery catheterization (PAC) and thermodilution are believed to be the gold standard by clinicians due to their greater reliability in measuring blood flow, their highly invasive nature is leading to complications. This is resulting in a gradual shift in the practice of hemodynamic monitoring at the bedside in the ICU and perioperative settings with the usage of minimally invasive and non-invasive methods. Availability of greater evidence-base on validity and reliability of non-invasive technologies is expected to drive clinical trust and address the unmet needs to measure hemodynamic parameters early in the care continuum, in a safe way to plan the treatment course. While continuous non-invasive technologies for beat-to-beat monitoring like Bioreactance and arterial wave volume clamp pulse contour methods have gained wider adoption in non-critical settings, the Doppler ultrasound method has gained greater validity among clinicians to accurately measure parameters similar to the gold standard method of thermodilution. Until recently, the existing market leaders have succeeded by leveraging their scale and brand positioning to meet the market demands. However, sustaining growth and leadership necessitates well thought out R&D investments or collaborations with emerging start-ups, and even possible acquisitions to strength the product portfolio. Companies are also pivoting from a capital equipment and proprietary disposable driven business model to a software-based, long-term subscription and licensing contract model in their efforts to transition to value-based care and drive the adoption of hemodynamic monitoring across multiple clinical needs.

Increasing number of surgeries and chronic morbidities requiring critical care, along with the importance of goal-directed therapy for fluid management, has enabled greater adoption of hemodynamic monitoring systems in the market. While continuous invasive hemodynamic monitoring using the arterial line is the choice in critically ill and highly unstable patients undergoing surgery, continuous non-Invasive methods would become an alternative in surgical care in the medium term (3-5 years) to guide perioperative hemodynamic therapy and eventually improve postoperative outcome. Established companies are offering greater breadth of product lines (invasive, minimally invasive, and non-invasive) either by investing in R&D or acquiring complementary product companies to serve the varied needs of providers. Non-invasive hemodynamic monitoring systems are witnessing higher growth driven by the greater need to provide user-friendly, rapid cardiac output measurement with less complications and faster recovery time. Device makers and providers can ward off challenges arising in continuity of care and accessibility of patients due to unforeseen catastrophic situations like pandemic threats and other natural calamities by leveraging remote monitoring and patient-oriented wireless technologies. Software-based business models (SaaS) enable device companies to integrate hemodynamic monitoring capabilities in a plethora of bedside patient monitors which are an indispensable part of care provision in ICUs and surgical theaters.

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • Strategic Imperatives for the Hemodynamic Monitoring Systems Market
  • The Impact of the Top Three Strategic Imperatives on the Hemodynamic Monitoring Systems Market
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis, Hemodynamic Monitoring Systems Market

  • Hemodynamic Monitoring Systems Market, Definitions
  • Scope of Analysis
  • Segmentation by Care Setting
  • Segmentation by Products and Technologies
  • Hemodynamic Monitoring Systems, Key Competitors by Segments
  • Key Elements of Hemodynamic Monitoring
  • Key Aspects of an Ideal Hemodynamic Monitoring Method
  • Continuum of Care Approach
  • Key Impact Forces
  • Growth Trends
  • Key Growth Metrics for the Hemodynamic Monitoring Systems Market
  • Key Acquisitions
  • Technology Positioning
  • Growth Drivers for the Hemodynamic Monitoring Systems Market
  • Growth Restraints for the Hemodynamic Monitoring Systems Market
  • Forecast Assumptions, Hemodynamic Monitoring Systems Market
  • Revenue Forecast, Snapshot
  • Revenue Forecast, Hemodynamic Monitoring Systems Market
  • Revenue Forecast by Product, Hemodynamic Monitoring Systems
  • Revenue Forecast by Setting, Hemodynamic Monitoring Systems
  • Revenue Forecast by Region, Hemodynamic Monitoring Systems
  • Revenue Forecast by Technology (Invasive), Hemodynamic Monitoring Systems
  • Revenue Forecast by Technology (Minimally Invasive) Hemodynamic Monitoring Systems
  • Revenue Forecast by Technology (Non-Invasive), Hemodynamic Monitoring Systems
  • Revenue Forecast Analysis, Hemodynamic Monitoring Systems Market
  • Revenue Forecast Analysis, Hemodynamic Monitoring Systems Market (continued)
  • Revenue Forecast Analysis, Hemodynamic Monitoring Systems Market (continued)
  • Regional Trends, Snapshot
  • Revenue Forecast Analysis by Region, Hemodynamic Monitoring Systems
  • Competitive Environment, Hemodynamic Monitoring Systems
  • Revenue Share, Top Market Participants
  • Revenue Share Analysis, Top Participants
  • Competitive Environment, Key Competitors
  • Focus Areas of Key Competitors
  • Edwards Lifesciences
  • Nihon Kohden
  • ICU Medical
  • Getinge
  • Draeger
  • Fujifilm SonoSite
  • Deltex Medical
  • Vygon
  • Uscom
  • LiDCO
  • Fysicon (Canon Medical Group)
  • OSYPKA Medical (Cardiotronic)
  • NI Medical
  • Cheetah Medical (Baxter)
  • Philips
  • CNSystems
  • Hemodynamic Monitoring, Brief Profile of Other Emerging Companies/Start-ups

Growth Opportunity Analysis, Hemodynamic Monitoring Systems Market, NA

  • Key Growth Metrics for Hemodynamic Monitoring Systems, NA
  • Revenue Forecast, NA
  • Revenue Forecast by Product, NA
  • Forecast Analysis by Product, NA

Growth Opportunity Analysis, Hemodynamic Monitoring Systems Market, EU

  • Key Growth Metrics for Hemodynamic Monitoring Systems, EU
  • Revenue Forecast, EU
  • Revenue Forecast by Product, EU
  • Forecast Analysis by Product, EU

Growth Opportunity Analysis, Hemodynamic Monitoring Systems market, APAC

  • Key Growth Metrics for Hemodynamic Monitoring Systems, APAC
  • Revenue Forecast, APAC
  • Revenue Forecast by Product, APAC
  • Forecast Analysis by Product, APAC

Growth Opportunity Universe, Hemodynamic Monitoring Systems Market

  • Growth Opportunity 1-Integrated Platform Solutions which Offer Advanced Algorithms and Hybrid Capabilities
  • Growth Opportunity 1-Integrated Platform Solutions which Offer Advanced Algorithms and Hybrid Capabilities (continued)
  • Growth Opportunity 2-Non-invasive Products in Perioperative Setting
  • Growth Opportunity 2-Non-invasive Products in Perioperative Setting (continued)
  • Growth Opportunity 3-Software as a Service (SaaS) Business Model with Fixed Fee Renewable Contracts
  • Growth Opportunity 3-Software as a Service (SaaS) Business Model with Fixed Fee Renewable Contracts (continued)
  • Growth Opportunity 4-Wireless, Portable and Wearable Devices for Remote Monitoring in Alternative Care Settings
  • Growth Opportunity 4-Wireless, Portable and Wearable Devices for Remote Monitoring in Alternative Care Settings (continued)
  • Growth Opportunity 5-Increase in Critical Care Volumes and Rising Awareness in the APAC Market
  • Growth Opportunity 5-Increase in Critical Care Volumes and Rising Awareness in the APAC Market (continued)

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • List of Exhibits
  • List of Exhibits (continued)
  • List of Exhibits (continued)
  • Legal Disclaimer